• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能在药物设计中的应用:机遇与挑战。

Applications of Artificial Intelligence in Drug Design: Opportunities and Challenges.

机构信息

Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Cambridge, UK.

Department of Pure Mathematics and Mathematical Statistics, University of Cambridge, Cambridge, UK.

出版信息

Methods Mol Biol. 2022;2390:1-59. doi: 10.1007/978-1-0716-1787-8_1.

DOI:10.1007/978-1-0716-1787-8_1
PMID:34731463
Abstract

Artificial intelligence (AI) has undergone rapid development in recent years and has been successfully applied to real-world problems such as drug design. In this chapter, we review recent applications of AI to problems in drug design including virtual screening, computer-aided synthesis planning, and de novo molecule generation, with a focus on the limitations of the application of AI therein and opportunities for improvement. Furthermore, we discuss the broader challenges imposed by AI in translating theoretical practice to real-world drug design; including quantifying prediction uncertainty and explaining model behavior.

摘要

人工智能(AI)近年来发展迅速,并成功应用于药物设计等实际问题。在本章中,我们回顾了人工智能在虚拟筛选、计算机辅助合成规划和从头分子生成等药物设计问题中的最新应用,重点讨论了其中人工智能应用的局限性和改进机会。此外,我们还讨论了人工智能在将理论实践转化为实际药物设计方面所带来的更广泛挑战;包括量化预测不确定性和解释模型行为。

相似文献

1
Applications of Artificial Intelligence in Drug Design: Opportunities and Challenges.人工智能在药物设计中的应用:机遇与挑战。
Methods Mol Biol. 2022;2390:1-59. doi: 10.1007/978-1-0716-1787-8_1.
2
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.人工智能在计算机辅助药物发现中的概念。
Chem Rev. 2019 Sep 25;119(18):10520-10594. doi: 10.1021/acs.chemrev.8b00728. Epub 2019 Jul 11.
3
Artificial intelligence in drug discovery: recent advances and future perspectives.药物研发中的人工智能:最新进展与未来展望。
Expert Opin Drug Discov. 2021 Sep;16(9):949-959. doi: 10.1080/17460441.2021.1909567. Epub 2021 Apr 2.
4
Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries.人工智能和机器学习方法在药物设计中的应用:制药行业的挑战与机遇。
Mol Divers. 2022 Jun;26(3):1893-1913. doi: 10.1007/s11030-021-10326-z. Epub 2021 Oct 23.
5
Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.人工智能、机器学习和深度学习在现实药物设计案例中的应用。
Methods Mol Biol. 2022;2390:383-407. doi: 10.1007/978-1-0716-1787-8_16.
6
Artificial Intelligence in Drug Design: Are We Still There?药物设计中的人工智能:我们还在那里吗?
Curr Top Med Chem. 2022;22(30):2483-2492. doi: 10.2174/1568026623666221017143244.
7
Unleashing the power of generative AI in drug discovery.释放生成式人工智能在药物研发中的力量。
Drug Discov Today. 2024 Jun;29(6):103992. doi: 10.1016/j.drudis.2024.103992. Epub 2024 Apr 23.
8
Guided structure-based ligand identification and design via artificial intelligence modeling.基于人工智能建模的导向结构配体鉴定和设计。
Expert Opin Drug Discov. 2022 Jan;17(1):71-78. doi: 10.1080/17460441.2021.1979514. Epub 2021 Sep 23.
9
Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors.探索人工智能和机器学习模型在药物设计难题方面的应用及对制药行业未来的潜在影响。
Methods. 2023 Nov;219:82-94. doi: 10.1016/j.ymeth.2023.09.010. Epub 2023 Sep 29.
10
Application of Artificial Intelligence and Machine Learning in Drug Discovery.人工智能和机器学习在药物发现中的应用。
Methods Mol Biol. 2022;2390:113-124. doi: 10.1007/978-1-0716-1787-8_4.

引用本文的文献

1
Scaffold Hopping with Generative Reinforcement Learning.基于生成式强化学习的支架跳跃
J Chem Inf Model. 2025 Jul 14;65(13):6513-6525. doi: 10.1021/acs.jcim.5c00029. Epub 2025 Jun 26.
2
Machine Learning for Toxicity Prediction Using Chemical Structures: Pillars for Success in the Real World.利用化学结构进行毒性预测的机器学习:在现实世界中取得成功的支柱。
Chem Res Toxicol. 2025 May 19;38(5):759-807. doi: 10.1021/acs.chemrestox.5c00033. Epub 2025 May 2.
3
Graph neural processes for molecules: an evaluation on docking scores and strategies to improve generalization.

本文引用的文献

1
Neural network activation similarity: a new measure to assist decision making in chemical toxicology.神经网络激活相似性:一种辅助化学毒理学决策的新方法。
Chem Sci. 2020 Jun 24;11(28):7335-7348. doi: 10.1039/d0sc01637c.
2
Predicting retrosynthetic pathways using transformer-based models and a hyper-graph exploration strategy.使用基于Transformer的模型和超图探索策略预测逆合成途径。
Chem Sci. 2020 Mar 3;11(12):3316-3325. doi: 10.1039/c9sc05704h.
3
Could graph neural networks learn better molecular representation for drug discovery? A comparison study of descriptor-based and graph-based models.
用于分子的图神经过程:对接分数评估及提高泛化能力的策略
J Cheminform. 2024 Oct 23;16(1):115. doi: 10.1186/s13321-024-00904-2.
4
ACEGEN: Reinforcement Learning of Generative Chemical Agents for Drug Discovery.ACEGEN:用于药物发现的生成式化学试剂的强化学习。
J Chem Inf Model. 2024 Aug 12;64(15):5900-5911. doi: 10.1021/acs.jcim.4c00895. Epub 2024 Aug 2.
5
MolScore: a scoring, evaluation and benchmarking framework for generative models in de novo drug design.MolScore:一种用于从头药物设计中生成模型的评分、评估和基准测试框架。
J Cheminform. 2024 May 30;16(1):64. doi: 10.1186/s13321-024-00861-w.
6
Exploring the current and prospective role of artificial intelligence in disease diagnosis.探索人工智能在疾病诊断中的当前及未来作用。
Ann Med Surg (Lond). 2024 Jan 4;86(2):943-949. doi: 10.1097/MS9.0000000000001700. eCollection 2024 Feb.
7
On the difficulty of validating molecular generative models realistically: a case study on public and proprietary data.论切实验证分子生成模型的难度:基于公共数据和专有数据的案例研究
J Cheminform. 2023 Nov 21;15(1):112. doi: 10.1186/s13321-023-00781-1.
8
DataPype: A Fully Automated Unified Software Platform for Computer-Aided Drug Design.DataPype:一个用于计算机辅助药物设计的全自动统一软件平台。
ACS Omega. 2023 Oct 12;8(42):39468-39480. doi: 10.1021/acsomega.3c05207. eCollection 2023 Oct 24.
9
Augmented Hill-Climb increases reinforcement learning efficiency for language-based de novo molecule generation.增强爬山算法提高了基于语言的从头分子生成的强化学习效率。
J Cheminform. 2022 Oct 3;14(1):68. doi: 10.1186/s13321-022-00646-z.
10
Recurrent neural network (RNN) model accelerates the development of antibacterial metronidazole derivatives.递归神经网络(RNN)模型加速了抗菌甲硝唑衍生物的研发。
RSC Adv. 2022 Aug 15;12(35):22893-22901. doi: 10.1039/d2ra01807a. eCollection 2022 Aug 10.
图神经网络能否为药物发现学习更好的分子表示?基于描述符和基于图的模型的比较研究。
J Cheminform. 2021 Feb 17;13(1):12. doi: 10.1186/s13321-020-00479-8.
4
Comparison of Cellular Morphological Descriptors and Molecular Fingerprints for the Prediction of Cytotoxicity- and Proliferation-Related Assays.细胞形态描述符和分子指纹预测细胞毒性和增殖相关测定的比较。
Chem Res Toxicol. 2021 Feb 15;34(2):422-437. doi: 10.1021/acs.chemrestox.0c00303. Epub 2021 Feb 1.
5
Inductive transfer learning for molecular activity prediction: Next-Gen QSAR Models with MolPMoFiT.用于分子活性预测的归纳迁移学习:基于MolPMoFiT的下一代QSAR模型。
J Cheminform. 2020 Apr 22;12(1):27. doi: 10.1186/s13321-020-00430-x.
6
Proteochemometrics - recent developments in bioactivity and selectivity modeling.药物化学计量学——生物活性和选择性建模的最新进展。
Drug Discov Today Technol. 2019 Dec;32-33:89-98. doi: 10.1016/j.ddtec.2020.08.003. Epub 2020 Sep 20.
7
Convergence of multiple synthetic paradigms in a universally programmable chemical synthesis machine.多种合成范式在通用可编程化学合成机器中的汇聚。
Nat Chem. 2021 Jan;13(1):63-69. doi: 10.1038/s41557-020-00596-9. Epub 2020 Dec 22.
8
Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet.人工智能在药物研发中的应用:哪些是现实的,哪些是虚幻的?第 1 部分:产生影响的途径,以及我们为何尚未实现。
Drug Discov Today. 2021 Feb;26(2):511-524. doi: 10.1016/j.drudis.2020.12.009. Epub 2020 Dec 17.
9
AiZynthFinder: a fast, robust and flexible open-source software for retrosynthetic planning.人工智能合成路线搜索工具(AiZynthFinder):一款用于逆合成规划的快速、强大且灵活的开源软件。
J Cheminform. 2020 Nov 17;12(1):70. doi: 10.1186/s13321-020-00472-1.
10
Open Targets Platform: supporting systematic drug-target identification and prioritisation.Open Targets 平台:支持系统性药物靶点识别和优先级排序。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1302-D1310. doi: 10.1093/nar/gkaa1027.